These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4905199)

  • 41. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of Hodgkin's malignant lymphoma in children and adolescents by immunomodulation with a dialysate of human leukocytes].
    Mydlil J
    Cesk Pediatr; 1991 May; 46(5):266-9. PubMed ID: 1893465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cellular immunity and clinico-histological stage in Hodgkin's disease].
    Fabris C; De Sanctis C; Ciriotti G; Ponzone A
    Minerva Pediatr; 1971 Feb; 23(5):190-3. PubMed ID: 5574421
    [No Abstract]   [Full Text] [Related]  

  • 44. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
    Amlot PL; Unger A
    Clin Exp Immunol; 1976 Dec; 26(3):520-7. PubMed ID: 1009684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of splenectomy and radiotherapy on lymphocytes in Hodgkin's disease.
    Sutherland RM; McCredie JA; Inch WR
    Clin Oncol; 1975 Dec; 1(4):275-84. PubMed ID: 1082407
    [No Abstract]   [Full Text] [Related]  

  • 46. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA; Caviles AP; Mendelsohn J
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.
    Björkholm M; Holm G; Mellstedt H; Pettersson D
    Clin Exp Immunol; 1975 Dec; 22(3):373-7. PubMed ID: 131665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostaglandin-producing suppressor cells in Hodgkin's disease.
    Goodwin JS; Messner RP; Bankhurst AD; Peake GT; Saiki JH; Williams RC
    N Engl J Med; 1977 Nov; 297(18):963-8. PubMed ID: 409950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous production of an inhibitor in vitro lymphocyte migration by lymphocytes from patients with Hodgkin's disease and mycosis fungoides.
    Skopińska-Rónzewska E; Zółtowska A; Dziewulska-Bokiniec A
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):57-62. PubMed ID: 6756337
    [No Abstract]   [Full Text] [Related]  

  • 51. Lymphocyte transformation changes during the clinical course of Hodgkin's disease.
    Jackson SM; Garrett JV; Craig AW
    Cancer; 1970 Apr; 25(4):843-50. PubMed ID: 5443106
    [No Abstract]   [Full Text] [Related]  

  • 52. [Blastic transformation of lymphocytes in culture as a test in the evaluation of the immunological state of patients with cancer].
    Pluzańska A
    Nowotwory; 1971; 21(4):261-5. PubMed ID: 5138712
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical condition of patients with Hodgkin's disease and the mitotic index in white blood cell cultures after stimulation with phytohemagglutinin.
    Pluzańska A
    Pol Med J; 1970; 9(4):841-6. PubMed ID: 5477491
    [No Abstract]   [Full Text] [Related]  

  • 54. Deficiency of lymphocyte antigen recognition in Hodgkin's disease.
    Gaines JD; Gilmer MA; Remington JS
    Natl Cancer Inst Monogr; 1973 May; 36():117-21. PubMed ID: 4744572
    [No Abstract]   [Full Text] [Related]  

  • 55. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Presence of cells with a high content of DNA in the circulating blood of 2 patients with malignant lymphoma. Blastic response of blood lymphocytes to PHA].
    Chilosi M; Nigro M
    Pathologica; 1974; 66(957-958):287-93. PubMed ID: 4453436
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
    Holm G; Björkholm M; Mellstedt H; Johansson B
    Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lymphocytes and Hodgkin's disease. Study of crossing and blastogenesis].
    Cavallero P; Sartoris S; Vergnano F
    Minerva Med; 1972 Sep; 63(60):3255-7. PubMed ID: 5054008
    [No Abstract]   [Full Text] [Related]  

  • 59. [Research on the prognostic value of immunodeficiency in Hodgkin's disease].
    Szász B; Dudea C; Róna L; Kifor I; Borsai G; Zegrean G; Rad L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):511-20. PubMed ID: 6113670
    [No Abstract]   [Full Text] [Related]  

  • 60. Relation of cell-mediated immunity to staging, histology and prognosis in untreated patients with Hodgkin's disease.
    De Gast GC; Halie MR
    Neth J Med; 1976; 19(4-5):196-200. PubMed ID: 980187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.